BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31130152)

  • 1. Cerebrospinal fluid biomarkers in patients with central nervous system infections: a retrospective study.
    Di Stefano A; Alcantarini C; Atzori C; Lipani F; Imperiale D; Burdino E; Audagnotto S; Mighetto L; Milia MG; Di Perri G; Calcagno A
    CNS Spectr; 2020 Jun; 25(3):402-408. PubMed ID: 31130152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients.
    Calcagno A; Atzori C; Romito A; Vai D; Audagnotto S; Stella ML; Montrucchio C; Imperiale D; Di Perri G; Bonora S
    J Neurovirol; 2016 Feb; 22(1):88-92. PubMed ID: 26246357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low cerebrospinal fluid Amyloid-βeta 1-42 in patients with tuberculous meningitis.
    Stroffolini G; Guastamacchia G; Audagnotto S; Atzori C; Trunfio M; Nigra M; Di Stefano A; Di Perri G; Calcagno A
    BMC Neurol; 2021 Nov; 21(1):449. PubMed ID: 34784880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study.
    Eckerström M; Nilsson S; Zetterberg H; Blennow K; Grahn A
    Sci Rep; 2020 Dec; 10(1):22400. PubMed ID: 33372192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections.
    Krut JJ; Zetterberg H; Blennow K; Cinque P; Hagberg L; Price RW; Studahl M; Gisslén M
    J Neurol; 2013 Feb; 260(2):620-6. PubMed ID: 23052602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid tau proteins in status epilepticus.
    Monti G; Tondelli M; Giovannini G; Bedin R; Nichelli PF; Trenti T; Meletti S; Chiari A
    Epilepsy Behav; 2015 Aug; 49():150-4. PubMed ID: 25958230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid biomarkers in patients with varicella-zoster virus CNS infections.
    Grahn A; Hagberg L; Nilsson S; Blennow K; Zetterberg H; Studahl M
    J Neurol; 2013 Jul; 260(7):1813-21. PubMed ID: 23471614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High neopterin and IP-10 levels in cerebrospinal fluid are associated with neurotoxic tryptophan metabolites in acute central nervous system infections.
    Quist-Paulsen E; Aukrust P; Kran AB; Dunlop O; Ormaasen V; Stiksrud B; Midttun Ø; Ueland T; Ueland PM; Mollnes TE; Dyrhol-Riise AM
    J Neuroinflammation; 2018 Nov; 15(1):327. PubMed ID: 30470234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteroviral meningitis reduces CSF concentration of Aβ42, but does not affect markers of parenchymal damage.
    Toczylowski K; Wojtkowska M; Sulik A
    Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1443-1447. PubMed ID: 31093802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus.
    Tyrberg T; Nilsson S; Blennow K; Zetterberg H; Grahn A
    J Neurovirol; 2020 Oct; 26(5):719-726. PubMed ID: 32816287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid and Tau Protein Concentrations in Children with Meningitis and Encephalitis.
    Sulik A; Toczylowski K; Kulczynska-Przybik A; Mroczko B
    Viruses; 2022 Mar; 14(4):. PubMed ID: 35458457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small cisterno-lumbar gradient of phosphorylated Tau protein in geriatric patients with suspected normal pressure hydrocephalus.
    Djukic M; Spreer A; Lange P; Bunkowski S; Wiltfang J; Nau R
    Fluids Barriers CNS; 2016 Aug; 13(1):15. PubMed ID: 27581842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.
    Peterson J; Gisslen M; Zetterberg H; Fuchs D; Shacklett BL; Hagberg L; Yiannoutsos CT; Spudich SS; Price RW
    PLoS One; 2014; 9(12):e116081. PubMed ID: 25541953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella zoster virus: an under-recognised cause of central nervous system infections?
    Parkes-Smith J; Chaudhuri A
    Intern Med J; 2022 Jan; 52(1):100-104. PubMed ID: 32896944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella-Zoster Virus Meningitis and Encephalitis: An Understated Cause of Central Nervous System Infections.
    Alvarez JC; Alvarez J; Tinoco J; Mellado P; Miranda H; Ferrés M; Forero J; Álvarez C
    Cureus; 2020 Nov; 12(11):e11583. PubMed ID: 33364107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau).
    Krut JJ; Price RW; Zetterberg H; Fuchs D; Hagberg L; Yilmaz A; Cinque P; Nilsson S; Gisslén M
    Virulence; 2017 Jul; 8(5):599-604. PubMed ID: 27435879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy.
    Schirinzi T; Sancesario GM; Di Lazzaro G; Scalise S; Colona VL; Imbriani P; Mercuri NB; Bernardini S; Lang AE; Pisani A
    J Neural Transm (Vienna); 2018 Sep; 125(9):1373-1379. PubMed ID: 29948175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF biomarkers and amyloid PET: concordance and diagnostic accuracy in a MCI cohort.
    Spallazzi M; Barocco F; Michelini G; Immovilli P; Taga A; Morelli N; Ruffini L; Caffarra P
    Acta Neurol Belg; 2019 Sep; 119(3):445-452. PubMed ID: 30847669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Cerebrospinal Fluid S100B Protein with Core Biomarkers and Cognitive Deficits in Prodromal and Mild Alzheimer's Disease.
    Christl J; Verhülsdonk S; Pessanha F; Menge T; Seitz RJ; Kujovic M; Höft B; Supprian T; Lange-Asschenfeldt C
    J Alzheimers Dis; 2019; 72(4):1119-1127. PubMed ID: 31683478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Diagnostic Performances Between Cerebrospinal Fluid Biomarkers and Amyloid PET in a Clinical Setting.
    Jung NY; Kim ES; Kim HS; Jeon S; Lee MJ; Pak K; Lee JH; Lee YM; Lee K; Shin JH; Ko JK; Lee JM; Yoon JA; Hwang C; Choi KU; Lee EC; Seong JK; Huh GY; Kim DS; Kim EJ
    J Alzheimers Dis; 2020; 74(2):473-490. PubMed ID: 32039853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.